A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia

Inclusion Criteria:

- Has a diagnosis of schizophrenia

- Requires acute treatment for symptoms of schizophrenia

- Willing and able to be confined to an inpatient study unit for up to 3-4 weeks

- Has experienced at least one previous hospitalization for schizophrenia

- Has been able to achieve outpatient status for more than 3 months in the past year

- Has a body mass index (BMI) between 18.0 and 40.0 kg/m^2

- Resides in a stable living situation when not hospitalized

- Has an identified reliable caregiver (for example, family member)

- Additional criteria may apply

Exclusion Criteria:

- Poses a current suicide risk

- Pregnant, planning to become pregnant, or breastfeeding

- Initiated first antipsychotic treatment within the past 12 months

- Has received a long-acting injectable antipsychotic in the past 3 months

- Has participated in a clinical study involving any investigational product within the
past 3 months, or is currently participating in a clinical study involving an
investigational product.

- A positive urine drug test for drugs of abuse

- Additional criteria may apply